UK industry advised to wake up to CE marking:
This article was originally published in Clinica
The Association of British Health-Care Industries has urged companies in the UK to make positive moves to find out if and how they should affix a CE mark to their products. Many companies in the UK are apparently still unprepared for or unaware of the June 14 deadline for CE marking of products, when the Medical Devices Directive becomes mandatory. Non-CE marked devices may still be put into service until June 30, 2001, provided they meet previously existing regulations (see Clinica No 778, p 6).
You may also be interested in...
Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.
The US FDA’s decision to ask on device adverse event reports whether the device involved had been serviced by a third party could help the agency as well as device makers, says Ricki Chase, compliance practice director at Lachman Consultant Services.